Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma [1]

British Journal of Haematology

Volumn 137, Issue 2, 2007, Pages 170-

  Lennard, Anne ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Enteropathy associated T cell lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DAUNORUBICIN DERIVATIVE; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISONE; VINCRISTINE SULFATE;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RESEARCH; DRUG EFFICACY; ENTEROPATHY; FEASIBILITY STUDY; HEALTH CARE POLICY; HEMATOLOGY; HUMAN; LETTER; PRIORITY JOURNAL; T CELL LYMPHOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CLINICAL PROTOCOLS; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; HUMANS; INTESTINAL DISEASES; LYMPHOMA, T-CELL, PERIPHERAL;

EID: 33947534023     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06532.x     Document Type: Letter

References (2)

1. Bishton, M.J. & Haynes, A.P. (2006) Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell Lymphoma. British Journal of Haematology, 136, 111-113.
2. Lennard, A.L., White, J. & Tiplady, C. (2002) Prospective evaluation of a novel treatment protocol for intestinal T cell NHL. Annals of Oncology, 12 (Suppl. 2), 130.